Epidemiology and clinical features of coronavirus disease 2019 in children.

Choi, Soo-Han; Kim, Han Wool; Kang, Ji-Man; Kim, Dong Hyun; Cho, Eun Young
Clinical and experimental pediatrics
2020Apr ; 63 ( 4 ) :125-132.
ÀúÀÚ »ó¼¼Á¤º¸
Choi, Soo-Han -
Kim, Han Wool -
Kang, Ji-Man -
Kim, Dong Hyun -
Cho, Eun Young -
ABSTRACT
Coronavirus disease-2019 (COVID-19), which started in Wuhan, China, in December 2019 and declared a worldwide pandemic on March 11, 2020, is a novel infectious disease that causes respiratory illness and death. Pediatric COVID-19 accounts for a small percentage of patients and is often milder than that in adults; however, it can progress to severe disease in some cases. Even neonates can suffer from COVID-19, and children may spread the disease in the community. This review summarizes what is currently known about COVID-19 in children and adolescents.
keyword
COVID-19; Child; Coronavirus; Infant; Newborn
¸µÅ©

ÁÖÁ¦ÄÚµå
ÁÖÁ¦¸í(Target field)
¿¬±¸´ë»ó(Population)
¿¬±¸Âü¿©(Sample size)
´ë»ó¼ºº°(Gender)
Áúº´Æ¯¼º(Condition Category)
¿¬±¸È¯°æ(Setting)
¿¬±¸¼³°è(Study Design)
¿¬±¸±â°£(Period)
ÁßÀç¹æ¹ý(Intervention Type)
ÁßÀç¸íĪ(Intervention Name)
Å°¿öµå(Keyword)
À¯È¿¼º°á°ú(Recomendation)
This review summarizes what is currently known about COVID-19 in children and adolescents; It is known that children comprise a small fraction of COVID-19 cases, and their symptoms are often mild. However, some pediatric cases may progress to severe disease, and initial atypical presentations may delay the diagnosis of COVID-19, leading to unfavorable outcomes.
¿¬±¸ºñÁö¿ø(Fund Source)
±Ù°Å¼öÁØÆò°¡(Evidence Hierarchy)
ÃâÆdz⵵(Year)
Âü¿©ÀúÀÚ¼ö(Authors)
´ëÇ¥ÀúÀÚ
DOI
10.3345/cep.2020.00535
KCDÄÚµå
ICD 03
°Ç°­º¸ÇèÄÚµå